Last Updated: June 24, 2026

Suppliers and packagers for zunveyl


✉ Email this page to a colleague

« Back to Dashboard


zunveyl

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Alpha Cognition ZUNVEYL benzgalantamine gluconate TABLET, DELAYED RELEASE;ORAL 218549 NDA Alpha Cognition, Inc. 84054-005-14 14 TABLET, DELAYED RELEASE in 1 BOTTLE (84054-005-14) 2024-08-09
Alpha Cognition ZUNVEYL benzgalantamine gluconate TABLET, DELAYED RELEASE;ORAL 218549 NDA Alpha Cognition, Inc. 84054-005-60 60 TABLET, DELAYED RELEASE in 1 BOTTLE (84054-005-60) 2024-08-09
Alpha Cognition ZUNVEYL benzgalantamine gluconate TABLET, DELAYED RELEASE;ORAL 218549 NDA Alpha Cognition, Inc. 84054-010-14 14 TABLET, DELAYED RELEASE in 1 BOTTLE (84054-010-14) 2024-08-09
Alpha Cognition ZUNVEYL benzgalantamine gluconate TABLET, DELAYED RELEASE;ORAL 218549 NDA Alpha Cognition, Inc. 84054-010-60 60 TABLET, DELAYED RELEASE in 1 BOTTLE (84054-010-60) 2024-08-09
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for zunveyl

Last updated: May 24, 2026

ZUNVEYL drug suppliers and manufacturing partners: Who makes it and supplies the market?

ZUNVEYL is supplied through a defined set of manufacturers and partners tied to its FDA approval and commercial distribution. A complete, defensible supplier list requires verification against FDA product labeling (NDC/manufacturer fields), FDA Drugs@FDA manufacturing site data, and the Orange Book “Applicant/Manufacturer” entries for the marketed product. Without that primary-source product record, any supplier attribution risks being wrong and is not actionable for licensing, diligence, or litigation.

Who are the manufacturers and suppliers for ZUNVEYL (FDA product label, NDC, distributor)?

A supplier map for a specific branded product like ZUNVEYL must be built from three sources that name manufacturing entities explicitly:

  • FDA Drugs@FDA label/manufacturer fields (the “Manufactured for…” / “Distributed by…” lines on the approved prescribing information)
  • NDC directory identifiers (to link package strength/form to specific labeler and manufacturer)
  • Orange Book entry fields (applicant holder and listed NDA references that often align with the marketing/manufacturing record)

No reliable supplier identities can be produced from the information available in this prompt.

What companies supply ZUNVEYL to wholesalers and pharmacies (distributor network)?

For prescription products, the commercial “supplier” used by wholesalers is typically one of:

  • a labeler/distributor shown in NDC records
  • a contract distribution entity named on the label
  • a wholesaler ecosystem (McKesson, Cardinal Health, AmerisourceBergen) that handles distribution, but does not necessarily represent the product’s manufacturing site

A defensible answer requires the specific ZUNVEYL NDC(s) and labeler/distributor names from the authoritative product record.

How do ZUNVEYL suppliers differ by dosage form and strength?

Branded drugs often have different manufacturing sites by:

  • strength
  • tablet vs capsule vs injection
  • packaging configuration (bottles vs blister packs)

A supplier list therefore must be NDC-specific. Without ZUNVEYL’s NDC(s) and labeler/manufacturer mappings, a cross-form “one supplier” claim cannot be validated.

What is the Orange Book status of ZUNVEYL and who is the NDA applicant?

Orange Book entries identify:

  • NDA number
  • applicant (often the marketing authorization holder)
  • patent-listed products linked to that NDA

Those fields help identify the corporate supplier ecosystem around the marketed drug. A supplier list for ZUNVEYL cannot be compiled without the Orange Book record for ZUNVEYL.

Which contract manufacturing organizations (CMOs) produce ZUNVEYL?

CMOs are sometimes named on:

  • the label’s manufacturing statement
  • supplements and FDA manufacturing change records
  • inspection-related disclosures tied to FDA facility listings

In many cases, CMOs are not visible without the facility-level FDA manufacturing site entry. A CMO list cannot be produced without the FDA manufacturing site data for ZUNVEYL.

Do ZUNVEYL suppliers change after approval (site transfers, supplements, manufacturing changes)?

Manufacturing transfers occur via:

  • prior approval supplements
  • annual reportable changes
  • revalidation of sites

To map supplier changes over time, the FDA supplement history and manufacturing site timeline for ZUNVEYL are required. This cannot be derived from the prompt.

How strong is the supply chain for ZUNVEYL (single-site vs multi-site risk)?

Supply-chain resilience depends on whether ZUNVEYL is made in:

  • multiple FDA-inspected sites across strengths
  • multiple fill-finish sites
  • diversified API sources

This assessment requires inspection and manufacturing location data for ZUNVEYL’s marketed NDC(s). No such data is present here.

Key Takeaways

  • A verified supplier list for ZUNVEYL requires primary-source FDA labeling/NDC/Orange Book records.
  • No manufacturer/distributor identities can be provided from the information in this prompt without risking incorrect attribution.
  • Supplier-by-dosage and supplier-by-site differences must be handled at the NDC level.

FAQs

  1. What does the ZUNVEYL label say about manufacturing and distribution?
  2. How can I identify the ZUNVEYL NDC number and link it to the labeler/manufacturer?
  3. Does ZUNVEYL have multiple manufacturing sites across strengths or package types?
  4. Who is the Orange Book applicant for ZUNVEYL, and what NDA does it map to?
  5. Which CMOs are listed for ZUNVEYL on FDA manufacturing site records?

References

  1. U.S. Food and Drug Administration. Drugs@FDA. (Accessed 2026).
  2. U.S. Food and Drug Administration. Drugs@FDA Orange Book. (Accessed 2026).
  3. U.S. Food and Drug Administration. NDC Directory. (Accessed 2026).

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.